These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2068489)

  • 1. [What is "mastopathy at risk" for the anatomopathologist?].
    Contesso G; Bertin F; Terrier P; Petit JY; Le M
    Rev Fr Gynecol Obstet; 1991 Jan; 86(1):9-12. PubMed ID: 2068489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mastopathy. Histological forms and long-term observations].
    Prechtel K
    Zentralbl Pathol; 1991; 137(3):210-9. PubMed ID: 1931894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The pathology of mastopathy and breast cancer].
    Prechtel K
    Radiologe; 1993 May; 33(5):236-42. PubMed ID: 8516434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The patho-epidemiology of benign proliferative epithelial disorders of the female breast.
    Cook MG; Rohan TE
    J Pathol; 1985 May; 146(1):1-15. PubMed ID: 3891937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond fibrocystic disease. The evolving concept of pre-malignant breast disease.
    Shirley SE
    West Indian Med J; 1999 Dec; 48(4):173-8. PubMed ID: 10639833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
    Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
    Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Locally and regionally limited breast cancer from the pathologist's view point].
    Gloor F
    Schweiz Med Wochenschr; 1977 Jul; 107(28):969-72. PubMed ID: 897635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.
    Worsham MJ; Raju U; Lu M; Kapke A; Cheng J; Wolman SR
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5474-9. PubMed ID: 17875777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [When must a mastopathy at risk be operated on? The viewpoint of the clinician, the radiologist, the surgeon, and the anatomopathologist].
    Gorins A; Dilhuydy MH; Petit JY; Contesso G
    Rev Fr Gynecol Obstet; 1991 Jan; 86(1):15-20. PubMed ID: 2068479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histology of precancerous lesions of the breast].
    Contesso G; Rouëssé J; Jacquemier J
    J Gynecol Obstet Biol Reprod (Paris); 1975; 4 SUPPL 2():5-20. PubMed ID: 1194641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [High-risk breast lesions].
    Bild E
    Rev Med Chir Soc Med Nat Iasi; 1998; 102(1-2):29-35. PubMed ID: 10756809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of benign and preinvasive breast diseases.
    Altaf FJ; Abdullah LS; Jamal AA
    Saudi Med J; 2004 Apr; 25(4):493-7. PubMed ID: 15083223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphologically detectable prestages of breast cancer].
    Prechtel K; Gehm O
    Osterr Z Onkol; 1975; 2(5):122-5. PubMed ID: 1243827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Histologic classification of breast cancer and its precancerous stages].
    Nizze H
    Zentralbl Gynakol; 1987; 109(1):3-14. PubMed ID: 3033949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cancer risk in breast lesions: diagnostic and therapeutic strategy].
    Bove F; Bilancio G; De Falco M; Parmeggiani D; Sperlongano P; Barbarisi A; Parmeggiani U
    Minerva Chir; 2003 Jun; 58(3):375-83. PubMed ID: 12955059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of stereotactic guidance of breast excisional biopsy versus stereotactic core biopsy in occult breast lesions].
    Wolf G; Helbich T
    Wien Med Wochenschr; 1998; 148(14):316-20. PubMed ID: 9816641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [What is mastopathy at risk? Epidemiologic and clinical basis].
    Gorins A; Kottler ML
    Rev Fr Gynecol Obstet; 1991 Jan; 86(1):4-8. PubMed ID: 2068485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial dysplasia in nipple aspirates of breast fluid: association with family history and other breast cancer risk factors.
    Petrakis NL; Ernster VL; King EB; Sacks ST
    J Natl Cancer Inst; 1982 Jan; 68(1):9-13. PubMed ID: 6948129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.